Vanguard Health Care ETF (NY:VHT)

330.66 +7.51 (+2.32%)

Delayed Quote Updated: 1:50 PM EDT, Oct 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vanguard Health Care ETF

< Previous 1 2 3 4 5 Next >

Hims & Hers Stock Sinks After-Hours As Weight-Loss Roadmap Gets Clouded — Retail Pounces On The Dip ↗

February 24, 2025

On the earnings call, CEO Andrew Dudum acknowledged that the transition would be "inevitable" for patients currently on compounded semaglutide.

Via Stocktwits

Topics Earnings

NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst ↗

February 24, 2025

Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH.

Via Benzinga

Hims & Hers Retail Traders Eye Robust Post-Earnings Rebound Following Stock’s Worst Drop On Semaglutide Update ↗

February 24, 2025

CEO Andrew Dudum acknowledged retail shareholders in a post on X, highlighting their deep research on the company and announcing plans to engage them directly on future earnings calls.

Via Stocktwits

Hims & Hers Hits New Highs On At-Home Lab Testing Plans: Retail Sees More Room To Run, Analysts Divided ↗

February 19, 2025

One analyst warned that elevated growth expectations could lead to near-term volatility as the company introduces its FY25 guidance.

Via Stocktwits

8 Trillion Reasons to Buy and Hold This Vanguard ETF ↗

November 16, 2023

This healthcare ETF could outperform the broader markets over the next decade.

Via The Motley Fool

Topics ETFs

Hims & Hers Stock: More Gains Ahead Or A Pullback? Most Retail Traders Bet On This Path ↗

February 18, 2025

A poll of over 4,000 respondents found that 47% believe the stock will continue its climb past $60, while 44% expect a significant pullback for profit-taking.

Via Stocktwits

US States Sue National Institutes Of Health Over $4 Billion Annual Cut In Biomedical Research Grant Budget ↗

February 11, 2025

A federal judge halted NIH's plan to cap indirect grant costs at 15%, citing potential harm to research. A hearing is set for February 21.

Via Benzinga

Prediction: The 2 Best Vanguard Index Funds in January Will Beat the S&P 500 in 2025 ↗

February 02, 2025

Via The Motley Fool

Topics Stocks

Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery ↗

January 24, 2025

Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved investor sentiment likely.

Via Benzinga

ETFs In Focus Post UnitedHealth's Mixed Q4 Results ↗

January 18, 2025

UnitedHealth Group, the largest U.S. health insurer, reported mixed fourth-quarter 2024 results. Shares of the stock dropped nearly 6% on the day following the results. This put various ETFs in the...

Via Talk Markets

Topics ETFs Stocks / Equities

Can the 5 Worst-Performing Stock Market Sectors in 2024 Beat the S&P 500 in 2025? ↗

January 09, 2025

Via The Motley Fool

Topics Stocks

S&P 500 Hits 57 All-Time Highs In Record-Breaking 2024: Magnificent 7 Drive 30% Of Nasdaq's Surge ↗

December 25, 2024

The year of milestones, 2024, has seen an unperturbed rise in the bull market, we recap 2024's landmark junctures in the U.S. stock market.

Via Benzinga

Topics Stocks

Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services ↗

December 19, 2024

U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending.

Via Benzinga

Why Are These 3 Vanguard ETFs Underperforming the S&P 500 Since Election Day? ↗

November 14, 2024

Stocks in these "safe" sectors are selling off as investors gravitate toward growth.

Via The Motley Fool

Topics ETFs Stocks

FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen' ↗

November 13, 2024

FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and highlighting uncertainty within the agency.

Via Benzinga

Topics Government

What Lies In Store For Healthcare ETFs In Q3 Earnings? ↗

October 27, 2024

The healthcare sector has performed well in recent months, driven by the booming weight-loss drug treatment segment. As such, various healthcare ETFs have benefited.

Via Talk Markets

Topics ETFs

Can You Lose Money Investing in ETFs? 3 Things to Know. ↗

September 26, 2024

ETFs can be safe yet powerful investments. But there are still risks involved.

Via The Motley Fool

Topics ETFs

Auto Stocks, Abortion, Health Care In Spotlight At DNC: Joe Biden, UAW President, Women Affected By Roe V. Wade Decision Headline Night 1 ↗

August 19, 2024

The first night of the Democratic National Convention (DNC) could have investors eyeing sectors like healthcare and automotive after key speeches.

Via Benzinga

Applying These 11 Stock Market Sectors Will Help Diversify Your Portfolio ↗

June 27, 2024

There is a classification system that separates the +5,000 publicly traded U.S. stocks into 11 sectors representing key areas of the economy. Choosing the right sectors can be a challenge so this...

Via Talk Markets

Topics Economy

2 Vanguard Funds Perfectly Positioned for the AI Revolution ↗

June 13, 2024

Artificial intelligence will radically transform these two sectors in less than a decade.

Via The Motley Fool

Topics Artificial Intelligence

Want $1 Million in Retirement? 2 ETFs to Buy Now and Hold for Decades ↗

June 03, 2024

These ETFs are an easy way to turn small but regular contributions into a $1 million retirement fund.

Via The Motley Fool

Topics ETFs Retirement

Should You Buy Vanguard's Hottest Sector-Based ETF? ↗

May 30, 2024

The communications sector could have more room to run, given its reasonable valuation and growth potential.

Via The Motley Fool

10 Best Vanguard Funds to Buy Right Now ↗

May 27, 2024

These 10 Vanguard stock ETFs can help you build a top-notch portfolio.

Via The Motley Fool

Topics ETFs

Can Ocugen Stock Keep Churning Higher? ↗

April 29, 2024

This tiny biotech caught fire in 2024. Can it sustain the momentum?

Via The Motley Fool

EXCLUSIVE: Pharma's Cloud Revolution — A $60B Market By 2030 With 1 Stock To Watch ↗

March 28, 2024

DiMarzio, VP & Portfolio Manager at Rockland Trust, highlights healthcare sector's potential for rebound & growth opportunities for investors.

Via Benzinga

Worried About a Market Correction? These 2 Defensive Vanguard Funds Are Pefect Safe Havens. ↗

February 22, 2024

These two Vanguard funds are top safe havens.

Via The Motley Fool

Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 ↗

December 29, 2023

According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.

Via Benzinga

S&P 500 Stuck In 4600-4800 Limbo For 2024? Wells Fargo Pinpoints 3 'Favored Sectors' For Next Year ↗

December 26, 2023

Wells Fargo Investment Institute has a 4600-4800 year-end 2024 target for the S&P 500 Index and 2000-2200 for the MSCI EAFE Index. Favored sectors are Health Care, Industrials, and Materials.

Via Benzinga

Topics Stocks

Analysis: Autoworkers Are A Missing Piece In The October Jobs Report. Here's Why That Matters. ↗

November 03, 2023

While the markets are focussing on the October jobs report missing expectations, here's a missing piece that may prove them wrong.

Via Benzinga

Bull Market or Recession? 2 Resilient Index Funds That Are Proven Moneymakers to Buy Now and Hold Forever (No Matter What Comes Next) ↗

October 21, 2023

Through economic booms and recessions, bull markets and bear markets, these resilient index funds have consistently made money for patient investors.

Via The Motley Fool

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.